Other risk groups include older adults, pregnant women, people taking metformin or long-term acid-suppressing medications (PPIs, H2 blockers), those with conditions affecting the gastrointestinal tract (pernicious anaemia, Crohn's disease, coeliac disease), and individuals who have undergone gastric or ileal surgery
They boost metabolism, increasing energy levels while promoting overall wellness
WADA's S0 prohibition is unaffected by the FDA timeline
Emerging research suggests BPC-157's benefits extend beyond direct tissue repair
SELECT Trial Investigators
This will allow for more sustained weight loss, and fewer side effects all while avoiding metabolic damage